Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The historical rank and industry rank for Hangzhou Alltest Biotech Co's OCF Margin % or its related term are showing as below:
SHSE:688606'
s OCF Margin % Range Over the Past 10 Years
Min: 3.28 Med: 30.38 Max: 54.84
Current: 18.34
During the past 10 years, the highest OCF Margin % of Hangzhou Alltest Biotech Co was 54.84%. The lowest was 3.28%. And the median was 30.38%.
SHSE:688606's OCF Margin % is ranked better than 75.46% of 815
companies
in the Medical Devices & Instruments industry
Industry Median: 5.86
vs SHSE:688606: 18.34
Hangzhou Alltest Biotech Co OCF Margin % Related Terms
Hangzhou Alltest Biotech Co OCF Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SHSE:688606 vs ISRG, BDX, MDLN: OCF Margin % Comparison
For the Medical Instruments & Supplies subindustry, Hangzhou Alltest Biotech Co's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Hangzhou Alltest Biotech Co OCF Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Hangzhou Alltest Biotech Co's OCF Margin % distribution charts can be found below:
* The bar in red indicates where Hangzhou Alltest Biotech Co's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Hangzhou Alltest Biotech Co (SHSE:688606) has a OCF Margin % of -16.47% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Hangzhou Alltest Biotech Co and its competitors. Over the past decade, Hangzhou Alltest Biotech Co's OCF Margin % has ranged from 3.28 to 54.84. According to the industry distribution chart, Hangzhou Alltest Biotech Co ranks #200 out of 815 companies in the Medical Devices & Instruments industry, placing it in the top 24.5%.
Is Hangzhou Alltest Biotech Co's OCF Margin % too high?
Hangzhou Alltest Biotech Co's current OCF Margin % is -16.47%. Over the past 10 years, this metric has ranged from a low of 3.28 to a high of 54.84. Based on the distribution chart, Hangzhou Alltest Biotech Co ranks #200 out of 815 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Hangzhou Alltest Biotech Co has a GF Score™ of 53/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Hangzhou Alltest Biotech Co's OCF Margin % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Hangzhou Alltest Biotech Co ranks #200 out of 815 companies for OCF Margin %. This places Hangzhou Alltest Biotech Co in the top 25% of its industry — outperforming the majority of peers. The industry median OCF Margin % is 5.86. Historically, Hangzhou Alltest Biotech Co's own OCF Margin % has ranged from 3.28 to 54.84 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Medical Devices & Instruments company?
The median OCF Margin % among Medical Devices & Instruments companies is 5.86, based on 815 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Hangzhou Alltest Biotech Co and its competitors. For the Medical Devices & Instruments industry, the median OCF Margin % is 5.86 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Hangzhou Alltest Biotech Co's current OCF Margin % is -16.47%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hangzhou Alltest Biotech Co stock overvalued right now?
Based on GuruFocus' analysis, Hangzhou Alltest Biotech Co (SHSE:688606) is currently considered Possible Value Trap. The stock's GF Value™ is ¥85.74, compared to a current price of ¥43.47 — trading 49.3% below its estimated fair value. The current OCF Margin % is -16.47%. Hangzhou Alltest Biotech Co's overall GF Score™ is 53/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Hangzhou Alltest Biotech Co (SHSE:688606), the current OCF Margin % is -16.47% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Hangzhou Alltest Biotech Co (SHSE:688606) Overvalued in 2026?
Based on GuruFocus' analysis, Hangzhou Alltest Biotech Co stock appears to be undervalued.
The current stock price of ¥43.47 is trading 49.3% below its estimated GF Value™ of ¥85.74.
GuruFocus considers Hangzhou Alltest Biotech Co to be Possible Value Trap.
Key valuation signals for SHSE:688606:
OCF Margin %: -16.47%
GF Value™: ¥85.74 vs. price of ¥43.47 (49.3% below fair value)
No single metric tells the full story. See the SHSE:688606 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688606 has been successfully added to your 
